SCP Investment’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-6,245
Closed -$1.65M 60
2018
Q2
$1.65M Buy
+6,245
New +$1.65M 0.82% 43